Patient characteristics before treatment
| Renal (+) | Renal (–) | p Value | |
|---|---|---|---|
| N | 30 | 27 | |
| Age (years, mean±SD) | 42.2±15.7 | 37.7±13.2 | 0.23* |
| Sex (male/female) | 8/22 | 3/24 | 0.29† |
| Disease duration (years, mean±SD) | 8.6±6.0 | 7.1±8.7 | 0.45* |
| BMI (mean±SD) | 20.2±3.8 | 20.9±3.1 | 0.49* |
| Dose of TAC at start (mg/day, mean±SD) | 1.6±0.9 | 1.7±0.7 | >0.05* |
| Dosage of PSL at start (mg/day, mean±SD) | 13.2±9.2 | 12.6±7.8 | >0.05* |
| Rate of ACE/ARB use | 15/30 (50.0%) | 6/27 (22.2%) | 0.028† |
| Rate of statin use | 11/30 (36.7%) | 6/27 (22.2%) | 0.184† |
*Analysis by Welch’s t test.†Analysis by Fisher's exact probability test.
ARB, angiotensin II receptor blocker; BMI, body mass index; PSL, prednisolone; TAC, tacrolimus.